N/A
Completed N=125
Persona TM Tibia Clinical Outcomes Study
Osteoarthritis · Rheumatoid Arthritis · Traumatic Arthritis · Polyarthritis
Source: ClinicalTrials.gov NCT03589300 ↗
Enrolled (actual)
125
Serious AEs
12.0%
Results posted
Jul 2024
Primary outcomePrimary: Radiograph Assessment of Progressive Tibial Radiolucencies — 110; 4; 3 Knees
Summary
The primary objective of this study is to evaluate clinical performance for the commercially available Persona TM Tibia used in primary cementless tibia total knee arthroplasty.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Radiograph Assessment of Progressive Tibial Radiolucencies |
110; 4; 3 | — |
| SECONDARY Oxford Knee Score |
95; 20 | — |
| SECONDARY Revision Rate |
146; 2 | — |
Eligibility Criteria
Inclusion Criteria
- Patient is at least 18 years of age.
- Patient qualifies for a primary cementless tibia total knee arthroplasty based on physical exam and medical history, including diagnosis of severe knee pain and disability due to at least one of the following:
- Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
- Collagen disorders and/or avascular necrosis of the femoral condyle.
- Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
- Moderate valgus, varus, or flexion deformities.
- The salvage of previously failed surgical attempts that did not include partial or total knee arthroplasty of the ipsilateral knee.
- Patient has participated in the study-related Informed Consent process.
- Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved Informed Consent Form.
- Patient is willing and able to complete scheduled study procedures and follow-up evaluations as described in the Informed Consent Form.
- Independent of study participation, patient is a candidate for commercially available cementless Persona TM tibial knee component, implanted in accordance with product labeling.
Exclusion Criteria
- Previous history of infection in the affected joint.
- Active local or systemic infection that may affect the prosthetic joint.
- Insufficient bone stock on femoral or tibial surfaces.
- Skeletal immaturity.
- Neuropathic arthropathy.
- Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb.
- A stable, painless arthrodesis in a satisfactory functional position.
- Severe instability secondary to the absence of collateral ligament integrity.
- Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin.
- Patient has previously received partial or total knee arthroplasty for the ipsilateral knee.
- Patient is currently participating in any other surgical intervention studies or pain management studies.
- Patient is known to be pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.).
- Patient has a known or suspected sensitivity or allergy to one or more of the implant materials.
Data sourced from ClinicalTrials.gov (NCT03589300). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.